DURECT Corporation 17,708,333 Shares of Common Stock (par value $0.0001 per share) Underwriting AgreementUnderwriting Agreement • February 5th, 2021 • Durect Corp • Pharmaceutical preparations • New York
DURECT Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of up to 17,708,333 shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”). The 17,708,333 shares of Common Stock to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 2,656,249 shares of Common Stock, which are collectively called the “Option Shares.” The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are collectively called the “Offered Shares.” Cantor Fitzgerald & Co. (“Cantor”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule A, the term “Representative” as u
